About 65 per cent Omicron cases are from reinfection, according to a study based in England.
The study led by Imperial College London researchers found that almost two out of every three Covid-positive participants reported having had Covid before.
The team concluded that past infection was associated with a high risk of reinfection with Omicron.
However, more work is needed to determine how many of the results are true reinfections or PCR tests which may have picked up old traces of the virus.
Risks of infection were found to increase among people living in large compared to single-person households, those in more deprived areas and among people of Asian, Black and other ethnicities, according to the findings.
"There is good news in our data in that infections had been rapidly dropping during January, but they are still extremely high and may have recently stalled at a very high prevalence," said Professor Paul Elliott, director of the REACT programme from Imperial's School of Public Health.
"Of particular concern is that there is rapidly increasing prevalence among children now they are back at school and, compared with December, prevalence in older people aged 65+ has increased seven- to 12-fold, which may lead to increased hospitalisations," he added.
The REACT (REal-time Assessment of Community Transmission) research team swap-tested thousands of volunteers across England.
Among the 3,582 swab-positive individuals reporting whether or not they had had previous infection, 2,315 reported a confirmed previous infection.
Further, the researchers also looked at existing, publicly available data on Covid-19 hospitalisations and deaths and compared these with the REACT data on infection rates.
They found that between February and May and September and December of 2021, there was a reduced risk of hospitalisation, and between February and December inclusive there was a consistently lower risk of death.
This is likely due to the impact of the vaccination programme and improved treatment.
"Vaccination remains the best way to protect yourself from severe disease and hospitalisation from Omicron, and I would urge anyone who has not done so to come forward for their first, second and third doses as soon as possible," ," said Dr Jenny Harries, Chief Executive of the UK Health Security Agency.
"The impact the vaccination is having on preventing severe disease and hospitalisations is clear to see," she said.
--IANS
rvt/shb/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)